组织芯片，组织微阵列

MPR803	前列腺癌组织芯片，附TNM、临床分期、Gleason分级和Gleason评分，80例/80点
点数	80	例数	80
行数	8	列数	10
点直径(mm)	1.5	厚度(µm)	5.0
组织阵列类型	石蜡包埋	种属	人类
QA/QC	H&E and IHC confirmed
Applications	Routine histology procedures including Immunohistochemistry (IHC) and In Situ Hybridization (ISH), protocols which can be found at our support page.
Notes	1.Please keep the slides at 4 ℃ after receiving, and make experiment within 3 months will be better. 2.Bake the slides for 30 minutes at 60℃ before the experiment; 3.Please choose a gentle repair method to avoid tissue detachment.

Legend:	Pro -Prostate
	AT () Hyperplasia () Malignant (*) Malignant (I) Malignant (II) Malignant (III) Malignant (IV)

TISSUE ARRAYS MPR803

	1	2	3	4	5	6	7	8	9	10
A	PRO	PRO	PRO	PRO	PRO	PRO	PRO	PRO	PRO	PRO
B	PRO	PRO	PRO	PRO	PRO	PRO	PRO	PRO	PRO	PRO
C	PRO	PRO	PRO	PRO	PRO	PRO	PRO	PRO	PRO	PRO
D	PRO	PRO	PRO	PRO	PRO	PRO	PRO	PRO	PRO	PRO
E	PRO	PRO	PRO	PRO	PRO	PRO	PRO	PRO	PRO	PRO
F	PRO	PRO	PRO	PRO	PRO	PRO	PRO	PRO	PRO	PRO
G	PRO	PRO	PRO	PRO	PRO	PRO	PRO	PRO	PRO	PRO
H	PRO	PRO	PRO	PRO	PRO	PRO	PRO	PRO	PRO	PRO

Pos	No	Age	Sex	Organ_Anatomic_Site	Pathology_diagnosis	Grade	TNM	Stage	Type	isBackUp
A1	1	70	M	Prostate	Adenocarcinoma 1(3+2)	*	T3N0M0	III	Malignant	N
A2	2	79	M	Prostate	Adenocarcinoma 1(3+3)	*	*	*	Malignant	N
A3	3	73	M	Prostate	Adenocarcinoma 2(3+4)	*	*	*	Malignant	N
A4	4	68	M	Prostate	Adenocarcinoma 1(3+3) (sparse)	*	T3N0M0	III	Malignant	N
A5	5	67	M	Prostate	Adenocarcinoma 2(3+4)	*	T2bN0M0	II	Malignant	N
A6	6	56	M	Prostate	Adenocarcinoma 2(3+4)	*	*	*	Malignant	N
A7	7	70	M	Prostate	Adenocarcinoma 2(3+4)	*	*	*	Malignant	N
A8	8	65	M	Prostate	Adenocarcinoma 2(3+4)	*	*	*	Malignant	N
A9	9	64	M	Prostate	Adenocarcinoma 2(3+4)	*	*	*	Malignant	N
A10	10	84	M	Prostate	Adenocarcinoma 2(3+4)	*	*	*	Malignant	N
B1	11	72	M	Prostate	Adenocarcinoma 2(3+4)	*	*	*	Malignant	N
B2	12	68	M	Prostate	Adenocarcinoma 2(3+4)	*	*	*	Malignant	N
B3	13	73	M	Prostate	Adenocarcinoma 3(4+3)	*	T1N0M0	I	Malignant	N
B4	14	64	M	Prostate	Adenocarcinoma 2(3+4)	*	*	*	Malignant	N
B5	15	71	M	Prostate	Adenocarcinoma 2(3+4)	*	T3N0M0	III	Malignant	N
B6	16	75	M	Prostate	Adenocarcinoma 2(3+4)	*	T2N0M0	II	Malignant	N
B7	17	57	M	Prostate	Adenocarcinoma 2(3+4)	*	T2N0M0	II	Malignant	N
B8	18	71	M	Prostate	Adenocarcinoma 2(3+4)	*	T2N0M0	II	Malignant	N
B9	19	66	M	Prostate	Adenocarcinoma 2(3+4)	*	T2aN0M0	II	Malignant	N
B10	20	64	M	Prostate	Adenocarcinoma 2(3+4)	*	T2N0M0	II	Malignant	N
C1	21	60	M	Prostate	Adenocarcinoma 2(3+4)	*	T2N0M0	II	Malignant	N
C2	22	72	M	Prostate	Adenocarcinoma 3(4+3) (interstitial)	*	T2N0M0	II	Malignant	N
C3	23	62	M	Prostate	Adenocarcinoma 3(4+3)	*	T3N1M0	IV	Malignant	N
C4	24	64	M	Prostate	Adenocarcinoma 3(4+3)	*	*	*	Malignant	N
C5	25	73	M	Prostate	Adenocarcinoma 3(4+3)	*	*	*	Malignant	N
C6	26	75	M	Prostate	Adenocarcinoma 3(4+3)	*	T3N0M0	III	Malignant	N
C7	27	65	M	Prostate	Adenocarcinoma 3(4+3)	*	T2aN0M0	I	Malignant	N
C8	28	69	M	Prostate	Adenocarcinoma 2(3+4)	*	T3N0M0	III	Malignant	N
C9	29	78	M	Prostate	Adenocarcinoma 4(4+4)	*	T2N0M0	II	Malignant	N
C10	30	82	M	Prostate	Adenocarcinoma 4(4+4)	*	T2aN0M0	II	Malignant	N
D1	31	71	M	Prostate	Adenocarcinoma 4(4+4)	*	*	*	Malignant	N
D2	32	72	M	Prostate	Adenocarcinoma 4(4+4)	*	*	*	Malignant	N
D3	33	91	M	Prostate	Adenocarcinoma 4(4+4) (sparse)	*	*	*	Malignant	N
D4	34	62	M	Prostate	Adenocarcinoma 3(4+3)	*	*	*	Malignant	N
D5	35	70	M	Prostate	Adenocarcinoma 4(4+4)	*	*	*	Malignant	N
D6	36	62	M	Prostate	Adenocarcinoma 4(4+4)	*	T2N0M0	II	Malignant	N
D7	37	20	M	Prostate	Adenocarcinoma 4(4+4)	*	T2aN0M0	II	Malignant	N
D8	38	66	M	Prostate	Adenocarcinoma 4(4+4)	*	*	*	Malignant	N
D9	39	61	M	Prostate	Adenocarcinoma 4(4+4)	*	T3N0M0	III	Malignant	N
D10	40	62	M	Prostate	Adenocarcinoma 4(4+4)	*	T2N0M0	I	Malignant	N
E1	41	69	M	Prostate	Adenocarcinoma 4(4+4)	*	T3N1M0	IV	Malignant	N
E2	42	72	M	Prostate	Adenocarcinoma 4(4+4)	*	T2N0M0	II	Malignant	N
E3	43	69	M	Prostate	Adenocarcinoma 4(5+3) (interstitial)	*	T3N0M0	III	Malignant	N
E4	44	75	M	Prostate	Adenocarcinoma 4(5+3)	*	*	*	Malignant	N
E5	45	71	M	Prostate	Adenocarcinoma 4(5+3)	*	*	*	Malignant	N
E6	46	64	M	Prostate	Adenocarcinoma 5(4+5)	*	T2N0M0	II	Malignant	N
E7	47	72	M	Prostate	Adenocarcinoma 5(4+5) (interstitial)	*	T3N0M0	III	Malignant	N
E8	48	78	M	Prostate	Adenocarcinoma 5(4+5)	*	*	*	Malignant	N
E9	49	79	M	Prostate	Adenocarcinoma 5(4+5)	*	*	*	Malignant	N
E10	50	72	M	Prostate	Adenocarcinoma 5(4+5)	*	*	*	Malignant	N
F1	51	81	M	Prostate	Adenocarcinoma 5(4+5)	*	*	*	Malignant	N
F2	52	75	M	Prostate	Adenocarcinoma 5(4+5)	*	*	*	Malignant	N
F3	53	76	M	Prostate	Adenocarcinoma 5(4+5)	*	*	*	Malignant	N
F4	54	87	M	Prostate	Adenocarcinoma 5(4+5)	*	T2N0M0	II	Malignant	N
F5	55	74	M	Prostate	Adenocarcinoma 5(4+5)	*	T2N0M0	II	Malignant	N
F6	56	72	M	Prostate	Adenocarcinoma 5(4+5)	*	T2N0M0	II	Malignant	N
F7	57	70	M	Prostate	Adenocarcinoma 5(4+5)	*	T3N0M0	III	Malignant	N
F8	58	66	M	Prostate	Adenocarcinoma 5(4+5)	*	T3aN0M0	III	Malignant	N
F9	59	81	M	Prostate	Adenocarcinoma 5(4+5)	*	T3aN0M0	III	Malignant	N
F10	60	68	M	Prostate	Adenocarcinoma 5(5+4)	*	*	*	Malignant	N
G1	61	84	M	Prostate	Hyperplasia	*	*	*	Hyperplasia	N
G2	62	63	M	Prostate	Hyperplasia	*	*	*	Hyperplasia	N
G3	63	65	M	Prostate	Hyperplasia	*	*	*	Hyperplasia	N
G4	64	78	M	Prostate	Hyperplasia	*	*	*	Hyperplasia	N
G5	65	70	M	Prostate	Hyperplasia	*	*	*	Hyperplasia	N
G6	66	70	M	Prostate	Hyperplasia	*	*	*	Hyperplasia	N
G7	67	68	M	Prostate	Hyperplasia	*	*	*	Hyperplasia	N
G8	68	64	M	Prostate	Hyperplasia	*	*	*	Hyperplasia	N
G9	69	48	M	Prostate	Hyperplasia	*	*	*	Hyperplasia	N
G10	70	80	M	Prostate	Hyperplasia	*	*	*	Hyperplasia	N
H1	71	67	M	Prostate	Cancer adjacent prostate tissue	*	*	*	AT	N
H2	72	91	M	Prostate	Cancer adjacent prostate tissue	*	*	*	AT	N
H3	73	60	M	Prostate	Cancer adjacent prostate tissue	*	*	*	AT	N
H4	74	67	M	Prostate	Cancer adjacent prostate tissue	*	*	*	AT	N
H5	75	64	M	Prostate	Cancer adjacent prostate tissue	*	*	*	AT	N
H6	76	82	M	Prostate	Cancer adjacent prostate tissue	*	*	*	AT	N
H7	77	66	M	Prostate	Cancer adjacent prostate tissue	*	*	*	AT	N
H8	78	64	M	Prostate	Cancer adjacent prostate tissue	*	*	*	AT	N
H9	79	66	M	Prostate	Cancer adjacent prostate tissue	*	*	*	AT	N
H10	80	68	M	Prostate	Cancer adjacent prostate tissue	*	*	*	AT	N
Tissue Marker